<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Theoretical Biology and Medical Modelling - Latest articles</title>
		<link>http://www.tbiomed.com</link>
		<description>The latest articles from Theoretical Biology and Medical Modelling (ISSN 1742-4682) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/20"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/19"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/18"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/17"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/16"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/15"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/14"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/13"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/12"/>			    
            
				    <rdf:li rdf:resource="http://www.tbiomed.com/content/5/1/11"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.tbiomed.com/content/5/1/20">
            
            <title>Extracting key information from historical data to quantify the transmission dynamics of smallpox</title>
			<description>Background:
Quantification of the transmission dynamics of smallpox is crucial for optimizing intervention strategies in the event of a bioterrorist attack. This article reviews basic methods and findings in mathematical and statistical studies of smallpox which estimate key transmission parameters from historical data. 
Main findings
First, critically important aspects in extracting key information from historical data are briefly summarized. We mention different sources of heterogeneity and potential pitfalls in utilizing historical records. Second, we discuss how smallpox spreads in the absence of interventions and how the optimal timing of quarantine and isolation measures can be determined. Case studies demonstrate the following. (1) The upper confidence limit of the 99th percentile of the incubation period is 22.2 days, suggesting that quarantine should last 23 days. (2) The highest frequency (61.8%) of secondary transmissions occurs 3-5 days after onset of fever so that infected individuals should be isolated before the appearance of rash. (3) The U-shaped age-specific case fatality implies a vulnerability of infants and elderly among non-immune individuals. Estimates of the transmission potential are subsequently reviewed, followed by an assessment of vaccination effects and of the expected effectiveness of interventions. 
Conclusions:
Current debates on bio-terrorism preparedness indicate that public health decision making must account for the complex interplay and balance between vaccination strategies and other public health measures (e.g. case isolation and contact tracing) taking into account the frequency of adverse events to vaccination. In this review, we summarize what has already been clarified and point out needs to analyze previous smallpox outbreaks systematically.</description>
			<link>http://www.tbiomed.com/content/5/1/20</link>
			
			 	<dc:creator>Hiroshi Nishiura, Stefan O Brockmann and Martin Eichner</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:20</dc:source>
			<dc:date>2008-08-20</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-20</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>20</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-20</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/19">
            
            <title>Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling</title>
			<description>Background:
There are various methods for predicting human pharmacokinetics. Among these, a whole body physiologically-based pharmacokinetic (WBPBPK) model is useful because it gives a mechanistic description. However, WBPBPK models cannot predict human pharmacokinetics with enough precision. This study was conducted to elucidate the primary reason for poor predictions by WBPBPK models, and to enable better predictions to be made without reliance on complex concepts.  
Methods:
The primary reasons for poor predictions of human pharmacokinetics were investigated using a generic WBPBPK model that incorporated a single adjusting compartment (SAC), a virtual organ compartment with physiological parameters that can be adjusted arbitrarily. The blood flow rate, organ volume, and the steady state tissue-plasma partition coefficient of a SAC were calculated to fit simulated to observed pharmacokinetics in the rat. The adjusted SAC parameters were fixed and scaled up to the human using a newly developed equation. Using the scaled-up SAC parameters, human pharmacokinetics were simulated and each pharmacokinetic parameter was calculated. These simulated parameters were compared to the observed data. Simulations were performed to confirm the relationship between the precision of prediction and the number of tissue compartments, including a SAC.  
Results:
Increasing the number of tissue compartments led to an improvement of the average-fold error (AFE) of total body clearances (CLtot) and half-lives (T1/2) calculated from the simulated human blood concentrations of 14 drugs. The presence of a SAC also improved the AFE values of a ten-organ model from 6.74 to 1.56 in CLtot, and from 4.74 to 1.48 in T1/2. Moreover, the within-2-fold errors were improved in all models; incorporating a SAC gave results from 0 to 79% in CLtot, and from 14 to 93% in T1/2 of the ten-organ model.  
Conclusions:
By using a SAC in this study, we were able to show that poor prediction resulted mainly from such physiological factors as organ blood flow rate and organ volume, which were not satisfactorily accounted for in previous WBPBPK models. The SAC also improved precision in the prediction of human pharmacokinetics. This finding showed that the methodology of our study may be useful for functionally reinforcing a WBPBPK model.</description>
			<link>http://www.tbiomed.com/content/5/1/19</link>
			
			 	<dc:creator>Hirotaka Ando, Shigeru Izawa, Wataru Hori and Ippei Nakagawa</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:19</dc:source>
			<dc:date>2008-08-08</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-19</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>19</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/18">
            
            <title>Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: inherent potential for biosynthetic versus "live" recombinant microbicides</title>
			<description>Background:
Herpes Simplex virus types 1 and 2 are enveloped viruses with a linear dsDNA genome of ~120-200 kb.  Genital infection with HSV-2 has been denoted as a major risk factor for acquisition and transmission of HIV-1. Developing biomedical strategies for HSV-2 prevention is thus a central strategy in reducing global HIV-1 prevalence. This paper details the protocol for the isolation of restriction endunucleases (REases) with potent activity against the HSV-2 genome and models two biomedical interventions for preventing HSV-2
Methods and results: Using the whole genome of HSV-2, 289 REases and the bioinformatics software Webcutter2; we searched for potential recognition sites by way of genome wide palindromics. REase application in HSV-2 biomedical therapy was modeled concomitantly. Of the 289 enzymes analyzed; 77(26.6%) had potential to cleave the HSV-2 genome in >100 but &lt;400 sites; 69(23.9%) in >400 but &lt;700 sites; and the 9(3.1%) enzymes: BmyI, Bsp1286I, Bst2UI, BstNI, BstOI, EcoRII, HgaI, MvaI, and SduI cleaved in more than 700 sites. But for the 4: PacI, PmeI, SmiI, SwaI that had no sign of activity on HSV-2 genomic DNA, all 130(45%) other enzymes cleaved &lt;100 times. In silico palindromics has a PPV of 99.5% for in situ REase activity (2) Two models detailing how the REase EcoRII may be applied in developing interventions against HSV-2  are presented: a nanoparticle for microbicide development and a "recombinant lactobacillus" expressing cell wall anchored receptor (truncated nectin-1) for HSV-2 plus EcoRII. 
Conclusion:
Viral genome slicing by way of these bacterially- derived R-M enzymatic peptides may have therapeutic potential in HSV-2 infection; a cofactor for HIV-1 acquisition and transmission.</description>
			<link>http://www.tbiomed.com/content/5/1/18</link>
			
			 	<dc:creator>Misaki Wayengera, Henry Kajumbula and Wilson Byarugaba</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:18</dc:source>
			<dc:date>2008-08-07</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-18</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/17">
            
            <title>The hyperbolic effect of density and strength of inter beta-cell coupling on islet bursting: a theoretical investigation</title>
			<description>Background:
Insulin, the principal regulating hormone of blood glucose, is released through the bursting of the pancreatic islets. Increasing evidence indicates the importance of islet morphostructure in its function, and the need of a quantitative investigation. Recently we have studied this problem from the perspective of islet bursting of insulin, utilizing a new 3D hexagonal closest packing (HCP) model of islet structure that we have developed. Quantitative non-linear dependence of islet function on its structure was found. In this study, we further investigate two key structural measures: the number of neighboring cells that each beta-cell is coupled to, nc, and the coupling strength, gc. 
Results:
beta-cell clusters of different sizes with number of beta-cells n_beta ranging from 1-343, nc from 0-12, and gc from 0-1000 pS, were simulated. Three functional measures of islet bursting characteristics - fraction of bursting beta-cells fb, synchronization index lambda, and bursting period Tb, were quantified. The results revealed a hyperbolic dependence on the combined effect of nc and gc.  From this we propose to define a dimensionless cluster coupling index or CCI, as a composite measure for islet morphostructural integrity. We show that the robustness of islet oscillatory bursting depends on CCI, with all three functional measures fb, lambda and Tb increasing monotonically with CCI when it is small, and plateau around CCI=1. 
Conclusion:
CCI is a good islet function predictor. It has the potential of linking islet structure and function, and providing insight to identify therapeutic targets for the preservation and restoration of islet beta-cell mass and function. </description>
			<link>http://www.tbiomed.com/content/5/1/17</link>
			
			 	<dc:creator>Aparna Nittala and Xujing Wang</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:17</dc:source>
			<dc:date>2008-08-03</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-17</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/16">
            
            <title>Does codon bias have an evolutionary origin?</title>
			<description>Background:
There is a 3-fold redundancy in the Genetic Code; most amino acids are encoded by more than one codon. These synonymous codons are not used equally; there is a Codon Usage Bias (CUB). This article will provide novel information about the origin and evolution of this bias.
Results:
Codon Usage Bias (CUB, defined here as deviation from equal usage of synonymous codons) was studied in 113 species. The average CUB was 29.3 +/- 1.1% (S.E.M, n=113) of the theoretical maximum and declined progressively with evolution and increasing genome complexity. A Pan-Genomic Codon Usage Frequency (CUF) Table was constructed to describe genome-wide relationships among codons. Significant correlations were found between the number of synonymous codons and (i) the frequency of the respective amino acids (ii) the size of CUB. Numerous, statistically highly significant, internal correlations were found among codons and the nucleic acids they comprise. These strong correlations made it possible to predict missing synonymous codons (wobble bases) reliably from the remaining codons or codon residues. 
Conclusions:
The results put the concept of "codon bias" into a novel perspective. The internal connectivity of codons indicates that all synonymous codons might be integrated parts of the Genetic Code with equal importance in maintaining its functional integrity.</description>
			<link>http://www.tbiomed.com/content/5/1/16</link>
			
			 	<dc:creator>Jan C Biro</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:16</dc:source>
			<dc:date>2008-07-30</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-16</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/15">
            
            <title>The velocity of the arterial pulse wave: a viscous-fluid shock wave in an elastic tube

</title>
			<description>Background:
The arterial pulse is a viscous-fluid shock wave that is initiated by blood ejected from the heart.  This wave travels away from the heart at a speed termed the pulse wave velocity (PWV).  The PWV increases during the course of a number of diseases, and this increase is often attributed to arterial stiffness.  As the pulse wave approaches a point in an artery, the pressure rises as does the pressure gradient.  This pressure gradient increases the rate of blood flow ahead of the wave.  The rate of blood flow ahead of the wave decreases with distance because the pressure gradient also decreases with distance ahead of the wave.  Consequently, the amount of blood per unit length in a segment of an artery increases ahead of the wave, and this increase stretches the wall of the artery.   As a result, the tension in the wall increases, and this results in an increase in the pressure of blood in the artery.
Methods:
An expression for the PWV is derived from an equation describing the flow-pressure coupling (FPC) for a pulse wave in an incompressible, viscous fluid in an elastic tube.  The initial increase in force of the fluid in the tube is described by an increasing exponential function of time.  The relationship between force gradient and fluid flow is approximated by an expression known to hold for a rigid tube.
Results:
For large arteries, the PWV derived by this method agrees with the Korteweg-Moens equation for the PWV in a non-viscous fluid.  For small arteries, the PWV is approximately proportional to the Korteweg-Moens velocity divided by the radius of the artery.  The PWV in small arteries is also predicted to increase when the specific rate of increase in pressure as a function of time decreases.  This rate decreases with increasing myocardial ischemia, suggesting an explanation for the observation that an increase in the PWV is a predictor of future myocardial infarction.  The derivation of the equation for the PWV that has been used for more than fifty years is analyzed and shown to yield predictions that do not appear to be correct.
Conclusions:
Contrary to the theory used for more than fifty years to predict the PWV, it speeds up as arteries become smaller and smaller.  Furthermore, an increase in the PWV in small arteries may in some cases be due to decreasing force of myocardial contraction rather than arterial stiffness.</description>
			<link>http://www.tbiomed.com/content/5/1/15</link>
			
			 	<dc:creator>Page R. Painter</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:15</dc:source>
			<dc:date>2008-07-29</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-15</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/14">
            
            <title>Correlation between nucleotide composition and folding energy of coding sequences with special attention to wobble bases</title>
			<description>Background:
The secondary structure and complexity of mRNA influences its accessibility to regulatory molecules (proteins, micro-RNAs), its stability and its level of expression. The mobile elements of the RNA sequence, the wobble bases, are expected to regulate the formation of structures encompassing coding sequences.
Results:
The sequence/folding energy (FE) relationship was studied by statistical, bioinformatic methods in 90 CDS containing 26,370 codons. I found that the FE (dG) associated with coding sequences is significant and negative (407 kcal/1000 bases, mean &#177; S.E.M.) indicating that these sequences are able to form structures. However, the FE has only a small free component, less than 10% of the total. The contribution of the 1st and 3rd codon bases to the FE is larger than the contribution of the 2nd (central) bases. It is possible to achieve a ~4-fold change in FE by altering the wobble bases in synonymous codons. The sequence/FE relationship can be described with a simple algorithm, and the total FE can be predicted solely from the sequence composition of the nucleic acid. The contributions of different synonymous codons to the FE are additive and one codon cannot replace another. The accumulated contributions of synonymous codons of an amino acid to the total folding energy of an mRNA is strongly correlated to the relative amount of that amino acid in the translated protein.
Conclusion:
Synonymous codons are not interchangable with regard to their role in determining the mRNA FE and the relative amounts of amino acids in the translated protein, even if they are indistinguishable in respect of amino acid coding.</description>
			<link>http://www.tbiomed.com/content/5/1/14</link>
			
			 	<dc:creator>Jan C Biro</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:14</dc:source>
			<dc:date>2008-07-29</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-14</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/13">
            
            <title>Heterogeneity in multistage carcinogenesis and mixture modeling</title>
			<description>Carcinogenesis is commonly described as a multistage process, in which stem cells are transformed into cancer cells via a series of mutations. In this article, we consider extensions of the multistage carcinogenesis model by mixture modeling. This approach allows us to describe population heterogeneity in a biologically meaningful way. We focus on finite mixture models, for which we prove identifiability. These models are applied to human lung cancer data from several birth cohorts. Maximum likelihood estimation does not perform well in this application due to the heavy censoring in our data. We thus use analytic graduation instead. Very good fits are achieved for models that combine a small high risk group with a large group that is quasi immune.</description>
			<link>http://www.tbiomed.com/content/5/1/13</link>
			
			 	<dc:creator>Sandro Gsteiger and Stephan Morgenthaler</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:13</dc:source>
			<dc:date>2008-07-21</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-13</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/12">
            
            <title>Fractal parameters and vascular networks: facts &amp; artifacts</title>
			<description>Background:
Several fractal and non-fractal parameters have been considered for the quantitative assessment of the vascular architecture, using a variety of test specimens and of computational tools. The fractal parameters have the advantage of being scale invariant, i.e. to be independent of the magnification and resolution of the images to be investigated, making easier the comparison among different setups and experiments.
Results:
The success of several commercial and/or free codes in computing the fractal parameters has been tested on well known exact models. Based on such a preliminary study, we selected the code Frac-lac in order to analyze images obtained by visualizing the angiogenetic process occurring in chick Chorio Allontoic Membranes (CAM), assumed to be paradigmatic of a realistic 2D vascular network. Among the parameters investigated, the fractal dimension Df proved to be the most robust estimator for CAM vascular networks. Moreover, only Df was able to discriminate between effective and elusive increases in vascularization after drug-induced angiogenic stimulations on CAMs.
Conclusion:
The fractal dimension Df is likely to be the most promising tool for monitoring the effectiveness of anti-angiogenic therapies in various clinical contexts.</description>
			<link>http://www.tbiomed.com/content/5/1/12</link>
			
			 	<dc:creator>Daniele Mancardi, Gianfranco Varetto, Enrico Bucci, Fabrizio Maniero and Caterina Guiot</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:12</dc:source>
			<dc:date>2008-07-17</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-12</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.tbiomed.com/content/5/1/11">
            
            <title>Introduction of an agent-based multi-scale modular architecture for dynamic knowledge representation of acute inflammation</title>
			<description>Background:
One of the greatest challenges facing biomedical research is the integration and sharing of vast amounts of information, not only for individual researchers, but also for the community at large. Agent Based Modeling (ABM) can provide a means of addressing this challenge via a unifying translational architecture for dynamic knowledge representation. This paper presents a series of linked ABMs representing multiple levels of biological organization. They are intended to translate the knowledge derived from in vitro models of acute inflammation to clinically relevant phenomenon such as multiple organ failure.Results and DiscussionABM development followed a sequence starting with relatively direct translation from in-vitro derived rules into a cell-as-agent level ABM, leading on to concatenated ABMs into multi-tissue models, eventually resulting in topologically linked aggregate multi-tissue ABMs modeling organ-organ crosstalk. As an underlying design principle organs were considered to be functionally composed of an epithelial surface, which determined organ integrity, and an endothelial/blood interface, representing the reaction surface for the initiation and propagation of inflammation. The development of the epithelial ABM derived from an in-vitro model of gut epithelial permeability is described. Next, the epithelial ABM was concatenated with the endothelial/inflammatory cell ABM to produce an organ model of the gut. This model was validated against in-vivo models of the inflammatory response of the gut to ischemia. Finally, the gut ABM was linked to a similarly constructed pulmonary ABM to simulate the gut-pulmonary axis in the pathogenesis of multiple organ failure. The behavior of this model was validated against in-vivo and clinical observations on the cross-talk between these two organ systems
Conclusion:
A series of ABMs are presented extending from the level of intracellular mechanism to clinically observed behavior in the intensive care setting. The ABMs all utilize cell-level agents that encapsulate specific mechanistic knowledge extracted from in vitro experiments. The execution of the ABMs results in a dynamic representation of the multi-scale conceptual models derived from those experiments. These models represent a qualitative means of integrating basic scientific information on acute inflammation in a multi-scale, modular architecture as a means of conceptual model verification that can potentially be used to concatenate, communicate and advance community-wide knowledge.</description>
			<link>http://www.tbiomed.com/content/5/1/11</link>
			
			 	<dc:creator>Gary An</dc:creator>
			
			<dc:source>Theoretical Biology and Medical Modelling 2008, 5:11</dc:source>
			<dc:date>2008-05-27</dc:date>
			<dc:identifier>doi:10.1186/1742-4682-5-11</dc:identifier>
			
			
							
					<prism:publicationName>Theoretical Biology and Medical Modelling</prism:publicationName>
					
			
							
					<prism:issn>1742-4682</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-27</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
